Before PAa | After PA | All | ||
---|---|---|---|---|
N Gender, n (%) | 21 | 33 | 54 | |
Male | 17 (81.0) | 30 (90.9) | 47 (87.0) | |
Female | 4 (19.0) | 3 (9.1) | 7 (13.0) | |
Age (yrs) Median (range) | 61.0 (39–71) | 64.0 (44–75) | 63.0 (39–75) | |
Race, n (%) | ||||
Caucasian | 21 (100.0) | 33 (100.0) | 54 (100.0) | |
Clinical Staging, n (%) | ||||
I (T1,N0,M0) | 1 (4.8) | 11 (33.3) | 12 (22.2) | |
II (T2,N0,M0) | 2 (9.5) | 7 (21.2) | 9 (16.7) | |
III (T3,N1-2 M0) | 17 (81.0) | 16 (48.5) | 33 (61.1) | |
Histology,n (%) | ||||
Epithelial | 18 (85.7) | 30 (90.9) | 48 (88.9) | |
Biphasic | 2 (9.5) | 1 (3.0) | 3 (5.6) | |
Desmoplastic | 1 (4.8) | 2 (6.1) | 3 (5.6) |